Literature DB >> 11173722

[Screening for diabetic retinopathy with ophthalmoscopy: the contribution of non-ophthalmologist practitioners seems possible].

A Chadli1, M Kebbou, M Ababou, Y El Mansouri, A El Amraoui.   

Abstract

Diabetic retinopathy is a severe and frequent complication of diabetes. Screening and early treatment of retinal lesions avoid blindness, but diagnosis is often established too late. The purpose of our study was to compare the concordance between the results of examination of fundus oculi whether performed by a previously trained non ophthalmologist physician at diabetes day center or during a routine ophthalmology consultation. Results were classified a posteriori in order to have binary response (presence of the lesion, absence of the lesion). Ninety six eyes were examined. Results of these examinations were compared using the kappa test agreement (kappa). The concordance was good for the majority of retinal lesions. The concordance in the results suggests that the contribution of non ophthalmologist physicians to the screening of diabetic retinopathy is possible and could facilitate the selection of patients who require specialized and elaborate ophthalmologic exploration.

Entities:  

Mesh:

Year:  2000        PMID: 11173722

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  2 in total

1.  No loss of chance of diabetic retinopathy screening by endocrinologists with a digital fundus camera.

Authors:  Natacha Germain; Bodgan Galusca; Nilanjana Deb-Joardar; Luc Millot; Pierre Manoli; Gilles Thuret; Philippe Gain; Bruno Estour
Journal:  Diabetes Care       Date:  2011-01-25       Impact factor: 19.112

2.  Diabetic foot syndrome and corneal subbasal nerve plexus changes in congolese patients with type 2 diabetes.

Authors:  Andrey Zhivov; Sabine Peschel; Hans-Christof Schober; Oliver Stachs; Simone Baltrusch; Marie Therese Bambi; Janvier Kilangalanga; Karsten Winter; Guenther Kundt; Rudolf F Guthoff
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.